A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Maja de Jonge; VA de Weger; MA Dickson; M Langenberg; A le Cesne; AJ Wagner; K Hsu; W Zheng; S Mace; G Tuffal; K Thomas; JHM Schellens

doi:10.1016/j.ejca.2017.02.005

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Maja de Jonge, VA de Weger, MA Dickson, M Langenberg, A le Cesne, AJ Wagner, K Hsu, W Zheng, S Mace, G Tuffal, K Thomas, JHM Schellens

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

83 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	144-151
Number of pages	8
Journal	European Journal of Cancer
Volume	76
DOIs	https://doi.org/10.1016/j.ejca.2017.02.005
Publication status	Published - 2017

Access to Document

10.1016/j.ejca.2017.02.005

http://hdl.handle.net/1765/108197

Cite this

@article{087ba7cfdb3f49f99a329d48c67eb6ca,

title = "A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours",

author = "{de Jonge}, Maja and {de Weger}, VA and MA Dickson and M Langenberg and {le Cesne}, A and AJ Wagner and K Hsu and W Zheng and S Mace and G Tuffal and K Thomas and JHM Schellens",

year = "2017",

doi = "10.1016/j.ejca.2017.02.005",

language = "Undefined/Unknown",

volume = "76",

pages = "144--151",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

AU - de Jonge, Maja

AU - de Weger, VA

AU - Dickson, MA

AU - Langenberg, M

AU - le Cesne, A

AU - Wagner, AJ

AU - Hsu, K

AU - Zheng, W

AU - Mace, S

AU - Tuffal, G

AU - Thomas, K

AU - Schellens, JHM

PY - 2017

Y1 - 2017

U2 - 10.1016/j.ejca.2017.02.005

DO - 10.1016/j.ejca.2017.02.005

M3 - Article

SN - 0959-8049

VL - 76

SP - 144

EP - 151

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -